MedTrace Logo

Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses

NCT00756288 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-12-06

No results posted yet for this study

Summary

Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy for the treatment of actinic keratoses.

Conditions

  • Actinic Keratoses

Interventions

PROCEDURE

Topical retinoid and blue-light therapy with photosensitizing agent

Topical Retinoid - Apply to AKs for 4 weeks Photo-therapy with photosensitizing agent- Apply to AKs at week 4

PROCEDURE

Photodynamic Therapy (PDT)

Photo-therapy with sensitizing agent - apply to AKs at week 4

Sponsors & Collaborators

Principal Investigators

  • Murad Alam, MD · Northwestern University Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-12-31
Completion
2017-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00756288 on ClinicalTrials.gov